Effects of Biliary Phospholipids on Cholesterol Crystallization and Growth in Gallstone Formation
Authors:
- 5 January 2023
- journal article
- review article
- Published by Springer Nature in Advances in Therapy
- Vol. 40 (3) , 743-768
Abstract
The prevalence of cholesterol gallstone disease is increasing, primarily due to the global epidemic of obesity associated with insulin resistance, and this trend leads to a considerable healthcare, financial, and social burden worldwide. Although phospholipids play an essential role in maintaining cholesterol solubility in bile through both mixed micelles and vesicles, little attention has been paid to the impact of biliary phospholipids on the pathogenesis of cholesterol gallstone formation. A reduction or deficiency of biliary phospholipids results in a distinctly abnormal metastable physical–chemical state of bile predisposing to supersaturation with cholesterol. Changes in biliary phospholipid concentrations influence cholesterol crystallization by yielding both liquid crystalline and “anhydrous” crystalline metastable intermediates, evolving into classical parallelogram-shaped cholesterol monohydrate crystals in supersaturated bile. As a result, five distinct crystallization pathways, A–E, have been defined, mainly based on the prime habits of liquid and solid crystals in the physiological or pathophysiological cholesterol saturation of gallbladder and hepatic bile. This review concisely summarizes the chemical structures and physical–chemical properties of biliary phospholipids and their physiological functions in bile formation and cholesterol solubility in bile, as well as comprehensively discusses the latest advances in the role of biliary phospholipids in cholesterol crystallization and growth in gallstone formation, largely based on the findings from clinical and animal studies and in vitro experiments. The insights gleaned from uncovering the cholelithogenic mechanisms are expected to form a fundamental framework for investigating the hitherto elusive events in the earliest stage of cholesterol nucleation and crystallization. This may help to identify better measures for early diagnosis and prevention in susceptible subjects and effective treatment of patients with gallstones.Keywords
Funding Information
- Foundation for the National Institutes of Health (DK106249, DK114516, DK126369)
This publication has 127 references indexed in Scilit:
- Genotype-Phenotype Relationships in the Low-Phospholipid-Associated Cholelithiasis Syndrome: A Study of 156 Consecutive PatientsHepatology, 2013
- Therapy of gallstone disease: What it was, what it is, what it will beWorld Journal of Gastrointestinal Pharmacology and Therapeutics, 2012
- Lith Genes and Genetic Analysis of Cholesterol Gallstone FormationGastroenterology Clinics of North America, 2010
- Effect of gallbladder hypomotility on cholesterol crystallization and growth in CCK-deficient miceBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2010
- Biliary lipids and cholesterol gallstone diseaseJournal of Lipid Research, 2009
- A mutation in the canalicular phospholipid transporter gene, ABCB4, is associated with cholestasis, ductopenia, and cirrhosis in adults†‡Hepatology, 2008
- Low phospholipid associated cholelithiasis: association with mutation in the MDR3/ABCB4 geneOrphanet Journal of Rare Diseases, 2007
- Origin of biliary phosphatidylcholines studied by coenzyme labelling with [1,1-2H2]ethanolBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1983
- Cholesterol Crystals and the Formation of Cholesterol GallstonesNew England Journal of Medicine, 1980
- Liquid Crystals in Human BileNature, 1973